CG Oncology, Inc.

US$75.99As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CGONHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR 29.33%
Div yield —
ROE (26.41%)
Biotechnology
Beta (5Y) 0.35
PE TTM —
TSR TTM 75.62%
Mkt cap US$6.787B
ROIC (19.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$86
13.59%
(96.28%)
Hold 6|7|1|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.51
1.65
1.67
1.61
23.79%
22.38%
14.28%
15.71%
Revenue$M
587.7
619.4
655.3
683.9
8.65%
8.92%
11.59%
19.57%
Peers (US$6.787B)
Cap (US$)
PE
6.899B
5.173x
Capital
TTM
5Y
10Y
Leveragex
0.289
(0.083)
(0.053)
EBIT/Intx
1.129
0.572
0.489
Own earn%
(81.96)
21.23
26.34
Sh yield%
39.37
51.90
53.08
Owners
Insiders/Inst%
6.35
47.53
Short interest%
0.74
SBC / revenue%
3.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
10–18
$1 testx
−0.2
Incr. ROIC%
4